Celadon Pharmaceuticals (LSE:CEL) Days Sales Outstanding : 1,405.02 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Days Sales Outstanding?

Celadon Pharmaceuticals's average Accounts Receivable for the six months ended in Dec. 2023 was €0.60 Mil. Celadon Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was €0.08 Mil. Hence, Celadon Pharmaceuticals's Days Sales Outstanding for the six months ended in Dec. 2023 was 1,405.02.

The historical rank and industry rank for Celadon Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

LSE:CEL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 365 Med: 365 Max: 2519.34
Current: 2519.34

During the past 5 years, Celadon Pharmaceuticals's highest Days Sales Outstanding was 2519.34. The lowest was 365.00. And the median was 365.00.

LSE:CEL's Days Sales Outstanding is ranked worse than
99.6% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs LSE:CEL: 2519.34

Celadon Pharmaceuticals's Days Sales Outstanding declined from Dec. 2022 (10,207.83) to Dec. 2023 (1,405.02).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Celadon Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Celadon Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Days Sales Outstanding Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

365.00

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial			-	11,778.27	10,207.83	22,589.44	1,405.02

Competitive Comparison of Celadon Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Days Sales Outstanding falls into.

Celadon Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Celadon Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0.087)	/	1 )	/	0.087	*	365
=	0.087					/	0.087	*	365
=	365.00

Celadon Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (1.114	+	0.087)	/	2 )	/	0.078	*	365 / 2
=	0.6005					/	0.078	*	365 / 2
=	1,405.02

Celadon Pharmaceuticals (LSE:CEL) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Celadon Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines